Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma

SIMPLE SUMMARY: A critical step in the success of immunotherapy is the presentation of tumor-derived peptides by the major histocompatibility complex I (MHC-I) of tumor cells. These neoantigens are potentially immunogenic and trigger immune responses orchestrated by cytotoxic cells. In malignant mes...

Descripción completa

Detalles Bibliográficos
Autores principales: Brossel, Hélène, Fontaine, Alexis, Hoyos, Clotilde, Jamakhani, Majeed, Willems, Mégane, Hamaidia, Malik, Willems, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269013/
https://www.ncbi.nlm.nih.gov/pubmed/34199066
http://dx.doi.org/10.3390/cancers13133211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269013/
https://www.ncbi.nlm.nih.gov/pubmed/34199066
http://dx.doi.org/10.3390/cancers13133211

Ejemplares similares